Emmanuel Nony

Emmanuel Nony is a seasoned professional in the field of biomedical research and development, currently serving as Director of External Innovation Europe and Head of Molecular Biotechnologies at Servier, where leadership of a 20-member team has driven advancements in innovative therapeutic solutions such as antisense oligonucleotides and biological drugs. Previously, Emmanuel held significant roles at Stallergenes Greer, including Global Head of Research, contributing to successful clinical phases for allergenic immunotherapy products, as well as at LFB, where a key discovery regarding fucose's role in monoclonal antibody activity was made. Academic credentials include a Ph.D. in Experimental and Clinical Pharmacology from Université Paris-Saclay and a Master’s degree in Cellular and Molecular Engineering from University of Lille 1 Sciences and Technology. Early career experiences include research roles at esteemed institutions such as Tokyo Metropolitan Institute for Geriatrics and Gerontology and EMBL, focusing on glycobiology and molecular biology.